))
What to Know About Bimekizumab for HS: Update from James Q. Del Rosso, DO
Manage episode 461543676 series 3570618
Content provided by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Approved late last year to treat HS, bimekizumab was the subject of several publications in 2024, including phase 3 pivotal trial data. AARS President James Q. Del Rosso, DO gives an update on key data considerations. You can watch Dr. Del Rosso's full discussion of trial design, efficacy data, and safety findings online at acneandrosacea.org.
The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!
9 episodes
Share
